Cargando…
Personalized Medicine in Allergy
Allergic disease is among the most common pathologies worldwide and its prevalence has constantly increased up to the present days, even if according to the most recent data it seems to be slightly slowing down. Allergic disease has not only a high rate of misdiagnosis and therapeutic inefficacy, bu...
Autores principales: | Ferrando, Matteo, Bagnasco, Diego, Varricchi, Gilda, Bernardi, Stefano, Bragantini, Alice, Passalacqua, Giovanni, Canonica, Giorgio Walter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102831/ https://www.ncbi.nlm.nih.gov/pubmed/27826958 http://dx.doi.org/10.4168/aair.2017.9.1.15 |
Ejemplares similares
-
Mepolizumab in the management of severe eosinophilic asthma in
adults: current evidence and practical experience
por: Varricchi, Gilda, et al.
Publicado: (2016) -
Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma
por: Bagnasco, Diego, et al.
Publicado: (2017) -
Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?
por: Varricchi, Gilda, et al.
Publicado: (2017) -
Anti-IL-5 and IL-5Ra: Efficacy and Safety of New Therapeutic Strategies in Severe Uncontrolled Asthma
por: Bagnasco, Diego, et al.
Publicado: (2018) -
Therapeutic interventions in severe asthma
por: Canonica, Giorgio Walter, et al.
Publicado: (2016)